Related content

Memantine for the treatment of dementia

By Wilcock G.K.  

Lancet Neurology, Vol. 2, Iss. 8, 2003-08 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite

No nerve growth factor response to treatment with memantine in adult rats

By Lang U. E.   Mühlbacher M.   Hesselink M. B.   Zajaczkowski W.   Danysz W.   Danker-Hopfe H.   Hellweg R.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 181-190

Springer Publishing Company

Access to resources Recommend Favorite

A placebo-controlled study of memantine for the treatment of human immunodeficiency virus–associated sensory neuropathy

By Schifitto Giovanni   Yiannoutsos Constantin   Simpson David   Marra Christina   Singer Elyse   Kolson Dennis   Nath Avindra   Berger Joseph   Navia Bradford   Group (ACTG) 301 Team Adult AIDS Clinical Trials  

Journal of NeuroVirology, Vol. 12, Iss. 4, 2006-08 ,pp. : 328-331

Ashgate Publishing Ltd

Access to resources Recommend Favorite

N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease

By  

Current Alzheimer Research, Vol. 9, Iss. 6, 2012-07 ,pp. : 746-758

Bentham Science Publishers

Access to resources Recommend Favorite

Letter to the Editor: “Amantadine and Memantine in Catatonic Schizophrenia”

By Carroll Brendan   Thomas Christopher   Jayanti Kameshwari  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 133-134

Informa Healthcare

Access to resources Recommend Favorite